USPTO serial 86353815
PHARMACOSCOPY
Reviewed by CopyMark Law Group
Reg. 4925065Status 710
- Filing date
- Status date
- Registration date
- Mar 29, 2016
- Examiner
- CLYBURN, CARLA DIONNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHARMACOSCOPY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CeMM - Forschungszentrum für Molekulare Medizin GmbH
Vienna, AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
CeMM - Forschungszentrum für Molekulare Medizin GmbH
Vienna, AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
CeMM - Forschungszentrum für Molekulare Medizin GmbH
Vienna, AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alison M. Caless
Alison M. Caless Cantor Colburn LLP20 Church StreetFloor 22Hartford, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical products for use in high-throughput screening assays or chemicals for use in industry and science; biochemical reagents or chemical reagents for in vitro use in laboratories for scientific use; biochemicals or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells other than for medical or veterinary use, in particular cells originating from blood or other tissues; in vitro diagnostic agents, namely, small molecules, polypeptides, antibodies, drugs, or other natural or laboratory-made products for scientific use; pharmaceutical and biochemical substances and preparations, in particular reagents for medical research | SECTION 8 - CANCELLED | — |
| 005 | Biochemical or chemical products for use in high-throughput screening assays for use in medical diagnosis and treatment; pharmaceutical and biochemical substances and preparations, in particular reagents for medical diagnosis of human diseases such as cancer, inflammation, and immune disorders; biochemical reagents for use in high-through put screening assays or chemical reagents for in vitro use in laboratories for medical purposes; chemical reagents for use in high-through put screening assays for in vitro use in laboratories for medical purposes; biochemical reagents for use in high-through put screening assays, or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells, in particular cells originating from blood or other tissues for medical use; diagnostic products, namely, reagents for medical purposes | SECTION 8 - CANCELLED | — |
| 009 | Apparatus, namely, cell culture dishes used for cell culture, testing and/or detecting effects of drugs on cell types, in particular cells originating from blood or other tissues; scientific, optical, measuring and monitoring apparatus and instruments, namely, cell sorting devices, microscopes, photometers, and digital cameras; electric apparatus and instruments, namely, automated epi-fluorescent and confocal fluorescent microscopes for use in laboratories for medical purposes; computer-aided analysis apparatus and installations for receiving, processing, transmitting and displaying data constructed therefrom; computer hardware and computer software for processing, displaying, and interpreting data, in particular for scientific and medical purposes; test microtiter plates, namely, laboratory medical equipment for cell culture, testing, and/or detecting effects of drugs on cell types | SECTION 8 - CANCELLED | — |
| 042 | Medical and pharmaceutical research and development; scientific research and development services; industrial research in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; industrial development in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; laboratory services for cell culture, testing, and/or detecting the effects of drugs on cell types, in particular cells originating from blood or other tissues; professional consultancy services in the field of medical and pharmaceutical research and development; contract research services in the field of diagnosis and therapy of cancer, inflammation, and immune disorders; computer programming | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PHARMACOSCOPY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 29, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 29, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 23, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 23, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 23, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 23, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 23, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 10, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 3, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 19, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 14, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 14, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 15, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 20, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2014 | NWAP | NEW APPLICATION ENTERED | — |